The first-quarter earnings season is heating up—both in tempo and the numbers themselves.

Suzanne Vranica covers the advertising and marketing industries and is part of The Wall Street Journal’s media & marketing bureau in New York. During her long tenure on the beat, she’s covered the ...

When the rollback was announced shortly after Trump took action against DEI programs in the federal government by executive ...

Dana Cimilluca is former Wall Street bureau chief at The Wall Street Journal, where he managed a group of reporters and editors covering banks, hedge funds, private-equity firms, M&A and IPOs. He ...

Pfizer ( ($PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Pfizer (PFE) has been the focus of ...

Summit Therapeutics' shares dropped 36% after ivonescimab data showed no significant survival benefit. Click to read if SMMT ...

With 1,320 rental apartments and a host of amenities, 25 Water Street is the country’s largest office-to-residential ...

Goldman Sachs Group Inc. is among about half a dozen Wall Street banks preparing to sell $4.25 billion of debt backing ...

So far, SpringWorks – which was spun out of Pfizer in 2017 and has recently received FDA approval for a second therapy for a ...

Cantor Fitzgerald initiated coverage on Pfizer, giving a neutral rating and a $24 target price. Despite recent analyst ...

In today’s CEO Daily: Diane Brady talks to Pfizer CEO Albert Bourla about defending science amid a backdrop of political ...

Goldman Sachs shareholders voted to approve pay packages, including hefty retention bonuses, for top executives CEO David ...